Custom Antibody Market Overview:

The Custom Antibody Market is projected to reach USD 652 million by 2026 from USD 393 million in 2021, at a CAGR of 10.6% during the forecast period. As such, an increase in research activity especially in the life sciences industry along with growing industry-academia collaborations are the primary growth drivers for this market. In addition, the objective behind custom antibody production is to acquire an antibody that performs well in a particular qualitative or quantitative immunodetection method. The quality of catalog antibodies (to ensure the reproducibility of results) is also an area of concern in this market, which is primarily why end users prefer custom-made antibodies.

Request For Sample: 

Covid-19 Impact On The Global Custom Antibody Market

A mix of established pharmaceutical companies, as well as small startups, have stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus. Vaccine-related research activities in pharmaceutical and biotechnology companies, research centers, and academic research institutes are considered essential and have been largely unaffected in operations and output. Due to the increase in research activities, both the availability of funding for research and the demand for antibodies, including custom antibodies, are expected to grow.

Download PDF: 

Market Segmentation:

By services, the antibody development segment accounted for the largest share of the custom antibody market in 2020.

Based on service, the custom antibody market is segmented into antibody development, antibody production & purification, and antibody fragmentation & labeling. In 2020, the antibody development segment accounted for the largest share in the custom antibody market. The large share of this segment can be attributed to the increasing focus of researchers on high-quality custom antibodies for reproducibility, which can be hampered when using commercially available antibodies.

By type, the monoclonal antibody accounted for the largest share of the custom antibody market in 2020.

Based on type, the custom antibody market is segmented into monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and other custom antibodies. The monoclonal antibodies segment accounted for the largest market share in 2020. This is because monoclonal antibodies provide high specificity and selectivity compared to other antibodies and are thus the preferred choice in all types of research studies.

By source, the mice accounted for the largest share of the custom antibody market in 2020.

Based on source, the custom antibody market has been segmented into mice, rabbits, and other sources. The mice segment accounted for the largest share of the custom antibody market in 2020. Mice are the most preferred hosts for research-use antibody production. Compared to other experimental animals, mice offer advantages of lower feeding costs and ease of maintenance & handling due to their small size.

Detailed Information: 

Key Players:

Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck Group (Germany), Cell Signaling Technology, Inc. (US), GenScript (China), BioLegend (US), Rockland Immunochemicals (US) are the prominent players operating in the custom antibody market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

[email protected]